Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Biopharmaceutical company appoints personnel, announces finances
June 6th, 2005
Memory Pharmaceuticals Corp. (MEMY) announced that it has appointed Tony Scullion, the company's president and chief executive officer, as full-time executive chairman of the company. James Sulat has been appointed president and chief executive officer of the company and will also join the company's board of directors. Jonathan J. Fleming, the current nonexecutive chairman, will remain a member of the board of directors. "When I first met Sulat several months ago, it was to discuss the possibility of his joining the company's board. I immediately recognized that his broad corporate experience and reputation, particularly as chief financial officer of...
Source: Biotech Business Week (2005-06-06)
|
